254 related articles for article (PubMed ID: 23360755)
1. Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice.
An N; Kraft AS; Kang Y
J Hematol Oncol; 2013 Jan; 6():12. PubMed ID: 23360755
[TBL] [Abstract][Full Text] [Related]
2. Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.
An N; Lin YW; Mahajan S; Kellner JN; Wang Y; Li Z; Kraft AS; Kang Y
Stem Cells; 2013 Jun; 31(6):1202-12. PubMed ID: 23495171
[TBL] [Abstract][Full Text] [Related]
3. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.
Mikkers H; Nawijn M; Allen J; Brouwers C; Verhoeven E; Jonkers J; Berns A
Mol Cell Biol; 2004 Jul; 24(13):6104-15. PubMed ID: 15199164
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence.
Luo Y; Li L; Zou P; Wang J; Shao L; Zhou D; Liu L
Transplantation; 2014 Jan; 97(1):20-9. PubMed ID: 24092377
[TBL] [Abstract][Full Text] [Related]
5. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.
Saurabh K; Scherzer MT; Shah PP; Mims AS; Lockwood WW; Kraft AS; Beverly LJ
Oncotarget; 2014 Sep; 5(18):8503-14. PubMed ID: 25238262
[TBL] [Abstract][Full Text] [Related]
6. Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival.
Hammerman PS; Fox CJ; Birnbaum MJ; Thompson CB
Blood; 2005 Jun; 105(11):4477-83. PubMed ID: 15705789
[TBL] [Abstract][Full Text] [Related]
7. PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4-mediated microenvironmental interactions (PIM1).
Decker S; Finter J; Forde AJ; Kissel S; Schwaller J; Mack TS; Kuhn A; Gray N; Follo M; Jumaa H; Burger M; Zirlik K; Pfeifer D; Miduturu CV; Eibel H; Veelken H; Dierks C
Mol Cancer Ther; 2014 May; 13(5):1231-45. PubMed ID: 24659821
[TBL] [Abstract][Full Text] [Related]
8. Self-renewal of murine embryonic stem cells is supported by the serine/threonine kinases Pim-1 and Pim-3.
Aksoy I; Sakabedoyan C; Bourillot PY; Malashicheva AB; Mancip J; Knoblauch K; Afanassieff M; Savatier P
Stem Cells; 2007 Dec; 25(12):2996-3004. PubMed ID: 17717068
[TBL] [Abstract][Full Text] [Related]
9. Thioredoxin mitigates radiation-induced hematopoietic stem cell injury in mice.
Sundaramoorthy P; Wang Q; Zheng Z; Jiao Y; Chen BJ; Doan PL; Chao NJ; Kang Y
Stem Cell Res Ther; 2017 Nov; 8(1):263. PubMed ID: 29141658
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice.
Ito CY; Li CY; Bernstein A; Dick JE; Stanford WL
Blood; 2003 Jan; 101(2):517-23. PubMed ID: 12393491
[TBL] [Abstract][Full Text] [Related]
11. Pim-1 levels determine the size of early B lymphoid compartments in bone marrow.
Domen J; van der Lugt NM; Acton D; Laird PW; Linders K; Berns A
J Exp Med; 1993 Nov; 178(5):1665-73. PubMed ID: 8228813
[TBL] [Abstract][Full Text] [Related]
12. Bid protects the mouse hematopoietic system following hydroxyurea-induced replicative stress.
Liu Y; Aiello A; Zinkel SS
Cell Death Differ; 2012 Oct; 19(10):1602-12. PubMed ID: 22522598
[TBL] [Abstract][Full Text] [Related]
13. PIM kinases 1, 2 and 3 in intracellular LIF signaling, proliferation and apoptosis in trophoblastic cells.
Mary Photini S; Chaiwangyen W; Weber M; Al-Kawlani B; Favaro RR; Jeschke U; Schleussner E; Morales-Prieto DM; Markert UR
Exp Cell Res; 2017 Oct; 359(1):275-283. PubMed ID: 28729093
[TBL] [Abstract][Full Text] [Related]
14. Developmental stage-specific effects of Pim-1 dysregulation on murine bone marrow B cell development.
Xu Z; Gwin KA; Li Y; Medina KL
BMC Immunol; 2016 Jun; 17(1):16. PubMed ID: 27287229
[TBL] [Abstract][Full Text] [Related]
15. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.
Brault L; Gasser C; Bracher F; Huber K; Knapp S; Schwaller J
Haematologica; 2010 Jun; 95(6):1004-15. PubMed ID: 20145274
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow connexin-43 expression is critical for hematopoietic regeneration after chemotherapy.
Presley CA; Lee AW; Kastl B; Igbinosa I; Yamada Y; Fishman GI; Gutstein DE; Cancelas JA
Cell Commun Adhes; 2005; 12(5-6):307-17. PubMed ID: 16531325
[TBL] [Abstract][Full Text] [Related]
17. SCL is required for normal function of short-term repopulating hematopoietic stem cells.
Curtis DJ; Hall MA; Van Stekelenburg LJ; Robb L; Jane SM; Begley CG
Blood; 2004 May; 103(9):3342-8. PubMed ID: 14726374
[TBL] [Abstract][Full Text] [Related]
18. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS
Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331
[TBL] [Abstract][Full Text] [Related]
19. The Pim protein kinases regulate energy metabolism and cell growth.
Beharry Z; Mahajan S; Zemskova M; Lin YW; Tholanikunnel BG; Xia Z; Smith CD; Kraft AS
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):528-33. PubMed ID: 21187426
[TBL] [Abstract][Full Text] [Related]
20. Partially differentiated ex vivo expanded cells accelerate hematologic recovery in myeloablated mice transplanted with highly enriched long-term repopulating stem cells.
Szilvassy SJ; Weller KP; Chen B; Juttner CA; Tsukamoto A; Hoffman R
Blood; 1996 Nov; 88(9):3642-53. PubMed ID: 8896435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
